Evaluating pharmacokinetic and pharmacodynamic interactions with computational models in supporting cumulative risk assessment.
about
Novel in vitro and mathematical models for the prediction of chemical toxicityAn Overview of Literature Topics Related to Current Concepts, Methods, Tools, and Applications for Cumulative Risk Assessment (2007-2016)Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps.Testicular development in male rats is sensitive to a soy-based diet in the neonatal period.Cumulative risk assessment: an overview of methodological approaches for evaluating combined health effects from exposure to multiple environmental stressors.Computational pharmacokinetics/pharmacodynamics of rifampin in a mouse tuberculosis infection modelApplication of physiologically based pharmacokinetic models in chemical risk assessment.Using physiologically-based pharmacokinetic models to incorporate chemical and non-chemical stressors into cumulative risk assessment: a case study of pesticide exposuresScience and decisions: advancing toxicology to advance risk assessment.A concentration addition model to assess activation of the pregnane X receptor (PXR) by pesticide mixtures found in the French diet.Quantitative cancer risk assessment for occupational exposures to asphalt fumes during built-up roofing asphalt (BURA) operations.Antifungal drugs combinations: a patent review 2000-2015.Deterministic models of inhalational anthrax in New Zealand white rabbits.
P2860
Q26851492-4C3CE1EF-99F6-4A9B-923A-D61576E38DB7Q30234908-E2B3B994-8810-4116-806E-FC355DBE02F6Q30841046-BCEABBDE-261D-4790-A4BB-DE6B2B1DDD42Q33826348-0D88B0D0-A744-4F9F-AF89-316E156E66C2Q35860423-BC664D7A-E5FA-4C93-9665-185F18C3B84EQ35864589-03BBCCA4-AB0C-4A41-B26D-CE71BD1E75EEQ35864986-B2A2BA32-AFF3-44D3-AFD0-F43CB0B23AB3Q36067638-AA50F16B-1B72-4623-8B52-AE5C86DE7E41Q36509007-144CFD09-B75A-4AEE-85B7-59EFC15C7EEBQ36801931-1A7EBD8E-A3D3-4854-A814-AC09E3254F0AQ38619784-59796083-BF2B-45DE-9FFE-B0D2D9BA6608Q38712653-9EBC557F-3B8A-4593-85B8-56A470597FCCQ41977427-9A0CD116-A408-47ED-9FEB-14807D265942
P2860
Evaluating pharmacokinetic and pharmacodynamic interactions with computational models in supporting cumulative risk assessment.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Evaluating pharmacokinetic and ...... ng cumulative risk assessment.
@ast
Evaluating pharmacokinetic and ...... ng cumulative risk assessment.
@en
type
label
Evaluating pharmacokinetic and ...... ng cumulative risk assessment.
@ast
Evaluating pharmacokinetic and ...... ng cumulative risk assessment.
@en
prefLabel
Evaluating pharmacokinetic and ...... ng cumulative risk assessment.
@ast
Evaluating pharmacokinetic and ...... ng cumulative risk assessment.
@en
P2093
P2860
P356
P1476
Evaluating pharmacokinetic and ...... ng cumulative risk assessment.
@en
P2093
Harvey Clewell
Jerry Campbell
Yu-Mei Tan
P2860
P304
P356
10.3390/IJERPH8051613
P577
2011-05-01T00:00:00Z
2011-05-19T00:00:00Z